Global Antithrombin (Recombinant) Market Growth 2022-2028
- LP 4891032
- 79 Pages
- March 2022
- Pharmaceuticals
The United States Antithrombin (Recombinant) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Antithrombin (Recombinant) market, reaching US$ million by the year 2028. As for the Europe Antithrombin (Recombinant) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Antithrombin (Recombinant) players cover LFB Biotechnologies, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Antithrombin (Recombinant) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Lyophilized Formulation
Lyophilized Powder
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
LFB Biotechnologies
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antithrombin (Recombinant) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Antithrombin (Recombinant) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Antithrombin (Recombinant) by Country/Region, 2017, 2022 & 2028
2.2 Antithrombin (Recombinant) Segment by Type
2.2.1 Lyophilized Formulation
2.2.2 Lyophilized Powder
2.3 Antithrombin (Recombinant) Sales by Type
2.3.1 Global Antithrombin (Recombinant) Sales Market Share by Type (2017-2022)
2.3.2 Global Antithrombin (Recombinant) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Antithrombin (Recombinant) Sale Price by Type (2017-2022)
2.4 Antithrombin (Recombinant) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Antithrombin (Recombinant) Sales by Application
2.5.1 Global Antithrombin (Recombinant) Sale Market Share by Application (2017-2022)
2.5.2 Global Antithrombin (Recombinant) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Antithrombin (Recombinant) Sale Price by Application (2017-2022)
3 Global Antithrombin (Recombinant) by Company
3.1 Global Antithrombin (Recombinant) Breakdown Data by Company
3.1.1 Global Antithrombin (Recombinant) Annual Sales by Company (2020-2022)
3.1.2 Global Antithrombin (Recombinant) Sales Market Share by Company (2020-2022)
3.2 Global Antithrombin (Recombinant) Annual Revenue by Company (2020-2022)
3.2.1 Global Antithrombin (Recombinant) Revenue by Company (2020-2022)
3.2.2 Global Antithrombin (Recombinant) Revenue Market Share by Company (2020-2022)
3.3 Global Antithrombin (Recombinant) Sale Price by Company
3.4 Key Manufacturers Antithrombin (Recombinant) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antithrombin (Recombinant) Product Location Distribution
3.4.2 Players Antithrombin (Recombinant) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Antithrombin (Recombinant) by Geographic Region
4.1 World Historic Antithrombin (Recombinant) Market Size by Geographic Region (2017-2022)
4.1.1 Global Antithrombin (Recombinant) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Antithrombin (Recombinant) Annual Revenue by Geographic Region
4.2 World Historic Antithrombin (Recombinant) Market Size by Country/Region (2017-2022)
4.2.1 Global Antithrombin (Recombinant) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Antithrombin (Recombinant) Annual Revenue by Country/Region
4.3 Americas Antithrombin (Recombinant) Sales Growth
4.4 APAC Antithrombin (Recombinant) Sales Growth
4.5 Europe Antithrombin (Recombinant) Sales Growth
4.6 Middle East & Africa Antithrombin (Recombinant) Sales Growth
5 Americas
5.1 Americas Antithrombin (Recombinant) Sales by Country
5.1.1 Americas Antithrombin (Recombinant) Sales by Country (2017-2022)
5.1.2 Americas Antithrombin (Recombinant) Revenue by Country (2017-2022)
5.2 Americas Antithrombin (Recombinant) Sales by Type
5.3 Americas Antithrombin (Recombinant) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antithrombin (Recombinant) Sales by Region
6.1.1 APAC Antithrombin (Recombinant) Sales by Region (2017-2022)
6.1.2 APAC Antithrombin (Recombinant) Revenue by Region (2017-2022)
6.2 APAC Antithrombin (Recombinant) Sales by Type
6.3 APAC Antithrombin (Recombinant) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Antithrombin (Recombinant) by Country
7.1.1 Europe Antithrombin (Recombinant) Sales by Country (2017-2022)
7.1.2 Europe Antithrombin (Recombinant) Revenue by Country (2017-2022)
7.2 Europe Antithrombin (Recombinant) Sales by Type
7.3 Europe Antithrombin (Recombinant) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antithrombin (Recombinant) by Country
8.1.1 Middle East & Africa Antithrombin (Recombinant) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Antithrombin (Recombinant) Revenue by Country (2017-2022)
8.2 Middle East & Africa Antithrombin (Recombinant) Sales by Type
8.3 Middle East & Africa Antithrombin (Recombinant) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antithrombin (Recombinant)
10.3 Manufacturing Process Analysis of Antithrombin (Recombinant)
10.4 Industry Chain Structure of Antithrombin (Recombinant)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antithrombin (Recombinant) Distributors
11.3 Antithrombin (Recombinant) Customer
12 World Forecast Review for Antithrombin (Recombinant) by Geographic Region
12.1 Global Antithrombin (Recombinant) Market Size Forecast by Region
12.1.1 Global Antithrombin (Recombinant) Forecast by Region (2023-2028)
12.1.2 Global Antithrombin (Recombinant) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antithrombin (Recombinant) Forecast by Type
12.7 Global Antithrombin (Recombinant) Forecast by Application
13 Key Players Analysis
13.1 LFB Biotechnologies
13.1.1 LFB Biotechnologies Company Information
13.1.2 LFB Biotechnologies Antithrombin (Recombinant) Product Offered
13.1.3 LFB Biotechnologies Antithrombin (Recombinant) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 LFB Biotechnologies Main Business Overview
13.1.5 LFB Biotechnologies Latest Developments
14 Research Findings and Conclusion
Table 1. Antithrombin (Recombinant) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Antithrombin (Recombinant) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Lyophilized Formulation
Table 4. Major Players of Lyophilized Powder
Table 5. Global Antithrombin (Recombinant) Sales by Type (2017-2022) & (K Units)
Table 6. Global Antithrombin (Recombinant) Sales Market Share by Type (2017-2022)
Table 7. Global Antithrombin (Recombinant) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Antithrombin (Recombinant) Revenue Market Share by Type (2017-2022)
Table 9. Global Antithrombin (Recombinant) Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Antithrombin (Recombinant) Sales by Application (2017-2022) & (K Units)
Table 11. Global Antithrombin (Recombinant) Sales Market Share by Application (2017-2022)
Table 12. Global Antithrombin (Recombinant) Revenue by Application (2017-2022)
Table 13. Global Antithrombin (Recombinant) Revenue Market Share by Application (2017-2022)
Table 14. Global Antithrombin (Recombinant) Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Antithrombin (Recombinant) Sales by Company (2020-2022) & (K Units)
Table 16. Global Antithrombin (Recombinant) Sales Market Share by Company (2020-2022)
Table 17. Global Antithrombin (Recombinant) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Antithrombin (Recombinant) Revenue Market Share by Company (2020-2022)
Table 19. Global Antithrombin (Recombinant) Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Antithrombin (Recombinant) Producing Area Distribution and Sales Area
Table 21. Players Antithrombin (Recombinant) Products Offered
Table 22. Antithrombin (Recombinant) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Antithrombin (Recombinant) Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Antithrombin (Recombinant) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Antithrombin (Recombinant) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Antithrombin (Recombinant) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Antithrombin (Recombinant) Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Antithrombin (Recombinant) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Antithrombin (Recombinant) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Antithrombin (Recombinant) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Antithrombin (Recombinant) Sales by Country (2017-2022) & (K Units)
Table 34. Americas Antithrombin (Recombinant) Sales Market Share by Country (2017-2022)
Table 35. Americas Antithrombin (Recombinant) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Antithrombin (Recombinant) Revenue Market Share by Country (2017-2022)
Table 37. Americas Antithrombin (Recombinant) Sales by Type (2017-2022) & (K Units)
Table 38. Americas Antithrombin (Recombinant) Sales Market Share by Type (2017-2022)
Table 39. Americas Antithrombin (Recombinant) Sales by Application (2017-2022) & (K Units)
Table 40. Americas Antithrombin (Recombinant) Sales Market Share by Application (2017-2022)
Table 41. APAC Antithrombin (Recombinant) Sales by Region (2017-2022) & (K Units)
Table 42. APAC Antithrombin (Recombinant) Sales Market Share by Region (2017-2022)
Table 43. APAC Antithrombin (Recombinant) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Antithrombin (Recombinant) Revenue Market Share by Region (2017-2022)
Table 45. APAC Antithrombin (Recombinant) Sales by Type (2017-2022) & (K Units)
Table 46. APAC Antithrombin (Recombinant) Sales Market Share by Type (2017-2022)
Table 47. APAC Antithrombin (Recombinant) Sales by Application (2017-2022) & (K Units)
Table 48. APAC Antithrombin (Recombinant) Sales Market Share by Application (2017-2022)
Table 49. Europe Antithrombin (Recombinant) Sales by Country (2017-2022) & (K Units)
Table 50. Europe Antithrombin (Recombinant) Sales Market Share by Country (2017-2022)
Table 51. Europe Antithrombin (Recombinant) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Antithrombin (Recombinant) Revenue Market Share by Country (2017-2022)
Table 53. Europe Antithrombin (Recombinant) Sales by Type (2017-2022) & (K Units)
Table 54. Europe Antithrombin (Recombinant) Sales Market Share by Type (2017-2022)
Table 55. Europe Antithrombin (Recombinant) Sales by Application (2017-2022) & (K Units)
Table 56. Europe Antithrombin (Recombinant) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Antithrombin (Recombinant) Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Antithrombin (Recombinant) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Antithrombin (Recombinant) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Antithrombin (Recombinant) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Antithrombin (Recombinant) Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Antithrombin (Recombinant) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Antithrombin (Recombinant) Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Antithrombin (Recombinant) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Antithrombin (Recombinant)
Table 66. Key Market Challenges & Risks of Antithrombin (Recombinant)
Table 67. Key Industry Trends of Antithrombin (Recombinant)
Table 68. Antithrombin (Recombinant) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Antithrombin (Recombinant) Distributors List
Table 71. Antithrombin (Recombinant) Customer List
Table 72. Global Antithrombin (Recombinant) Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Antithrombin (Recombinant) Sales Market Forecast by Region
Table 74. Global Antithrombin (Recombinant) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Antithrombin (Recombinant) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Antithrombin (Recombinant) Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Antithrombin (Recombinant) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Antithrombin (Recombinant) Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Antithrombin (Recombinant) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Antithrombin (Recombinant) Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Antithrombin (Recombinant) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Antithrombin (Recombinant) Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Antithrombin (Recombinant) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Antithrombin (Recombinant) Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Antithrombin (Recombinant) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Antithrombin (Recombinant) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Antithrombin (Recombinant) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Antithrombin (Recombinant) Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Antithrombin (Recombinant) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Antithrombin (Recombinant) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Antithrombin (Recombinant) Revenue Market Share Forecast by Application (2023-2028)
Table 92. LFB Biotechnologies Basic Information, Antithrombin (Recombinant) Manufacturing Base, Sales Area and Its Competitors
Table 93. LFB Biotechnologies Antithrombin (Recombinant) Product Offered
Table 94. LFB Biotechnologies Antithrombin (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. LFB Biotechnologies Main Business
Table 96. LFB Biotechnologies Latest Developments
List of Figures
Figure 1. Picture of Antithrombin (Recombinant)
Figure 2. Antithrombin (Recombinant) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antithrombin (Recombinant) Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Antithrombin (Recombinant) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Antithrombin (Recombinant) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Lyophilized Formulation
Figure 10. Product Picture of Lyophilized Powder
Figure 11. Global Antithrombin (Recombinant) Sales Market Share by Type in 2021
Figure 12. Global Antithrombin (Recombinant) Revenue Market Share by Type (2017-2022)
Figure 13. Antithrombin (Recombinant) Consumed in Hospital
Figure 14. Global Antithrombin (Recombinant) Market: Hospital (2017-2022) & (K Units)
Figure 15. Antithrombin (Recombinant) Consumed in Clinic
Figure 16. Global Antithrombin (Recombinant) Market: Clinic (2017-2022) & (K Units)
Figure 17. Global Antithrombin (Recombinant) Sales Market Share by Application (2017-2022)
Figure 18. Global Antithrombin (Recombinant) Revenue Market Share by Application in 2021
Figure 19. Antithrombin (Recombinant) Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Antithrombin (Recombinant) Revenue Market Share by Company in 2021
Figure 21. Global Antithrombin (Recombinant) Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Antithrombin (Recombinant) Revenue Market Share by Geographic Region in 2021
Figure 23. Global Antithrombin (Recombinant) Sales Market Share by Region (2017-2022)
Figure 24. Global Antithrombin (Recombinant) Revenue Market Share by Country/Region in 2021
Figure 25. Americas Antithrombin (Recombinant) Sales 2017-2022 (K Units)
Figure 26. Americas Antithrombin (Recombinant) Revenue 2017-2022 ($ Millions)
Figure 27. APAC Antithrombin (Recombinant) Sales 2017-2022 (K Units)
Figure 28. APAC Antithrombin (Recombinant) Revenue 2017-2022 ($ Millions)
Figure 29. Europe Antithrombin (Recombinant) Sales 2017-2022 (K Units)
Figure 30. Europe Antithrombin (Recombinant) Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Antithrombin (Recombinant) Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Antithrombin (Recombinant) Revenue 2017-2022 ($ Millions)
Figure 33. Americas Antithrombin (Recombinant) Sales Market Share by Country in 2021
Figure 34. Americas Antithrombin (Recombinant) Revenue Market Share by Country in 2021
Figure 35. United States Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Antithrombin (Recombinant) Sales Market Share by Region in 2021
Figure 40. APAC Antithrombin (Recombinant) Revenue Market Share by Regions in 2021
Figure 41. China Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Antithrombin (Recombinant) Sales Market Share by Country in 2021
Figure 48. Europe Antithrombin (Recombinant) Revenue Market Share by Country in 2021
Figure 49. Germany Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Antithrombin (Recombinant) Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Antithrombin (Recombinant) Revenue Market Share by Country in 2021
Figure 56. Egypt Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Antithrombin (Recombinant) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Antithrombin (Recombinant) in 2021
Figure 62. Manufacturing Process Analysis of Antithrombin (Recombinant)
Figure 63. Industry Chain Structure of Antithrombin (Recombinant)
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
